Efficacy News and Research

RSS

How effective is social distancing in fighting COVID-19?

Since the second wave of the coronavirus disease (COVID-19) emerged in Europe, many countries have imposed social distancing measures in the form of community quarantines and lockdowns. Wuhan City in China, where the virus first emerged, has been in lockdown since Jan. 23rd and is only just attempting to return to normal daily life.

29 Mar 2020

Lessons from the Spanish flu: Strict and early isolation really effective in minimizing disease spread

Large events are canceled, restaurants and non-essential businesses are closed, and in many states, residents have been asked to shelter in place, all to limit the spread and impact of the COVID-19 virus.

27 Mar 2020

Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19

Grifols today announces that it has entered into a formal collaboration with the US Government alongside other health agencies, to treat COVID-19 disease.

From GRIFOLS U.K. Ltd. 27 Mar 2020

New research initiative to investigate multi-species response to novel coronavirus

Scientists at Texas Biomedical Research Institute (Texas Biomed) today announced the launch of a comprehensive research initiative to investigate multiple animal species and their response to the novel coronavirus disease (COVID-19).

26 Mar 2020

Removing a gene prevents Type 1 diabetes in mice by disguising beta cells

Removing a gene from the cells that produce insulin prevents mice from developing Type 1 diabetes by sparing the cells an attack from their own immune system, a new UW-Madison study shows.

26 Mar 2020

Targeting specific histone deacetylase may be novel therapeutic strategy for NSCLC

The survival rates for patients with non-small cell lung cancer have improved greatly over the past decade thanks to several new targeted treatment options for patients.

26 Mar 2020

Does acupuncture relieve migraines?

Acupuncture is the subject of a new study from China published in The BMJ in March 2020, which reports that it is capable of reducing migraine headaches more effectively than either sham acupuncture or usual care.

25 Mar 2020

Smartphone data helps score US states on social distancing

On Tuesday, a data collection company took smartphone location data and used it to publish the world's first Social Distancing Scoreboard. This is the first, admittedly rough, attempt to virtually estimate how well states and counties in the US are complying with the official guidelines to stay at home.

25 Mar 2020

New molecular probes to study the behavior of opioid receptors

It could be an important step forward in the improvement of pain therapy: Thanks to newly developed molecular probes, the behavior of individual opioid receptors can now be studied in detail.

25 Mar 2020

Clinical trial launched to investigate safety and efficacy of antiviral drug for COVID-19

Physician-scientists at four University of California Health medical centers -- UC San Diego Health, UC San Francisco, UC Irvine Health and UC Davis Health -- have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir, an antiviral drug that has shown activity in animal models and human clinical trials of SARS-CoV, MERS-CoV, Ebola, Marburg and other viruses.

24 Mar 2020

Cannabidiol helps fight antibiotic-resistant bacteria

Since the discovery of penicillin in 1928 by Sir Alexander Fleming, antibiotics have saved millions of lives from fatal infections world-wide. However, with time bacteria have developed mechanisms to escape the effects of antibiotics - they have become resistant.

24 Mar 2020

ELS can be useful in measuring outcomes for treatment studies in intellectual disabilities

A multi-university team of researchers found that expressive language sampling can be useful in measuring outcomes in clinical trials targeting fragile X syndrome.

24 Mar 2020

Huge WHO trial of COVID-19 therapies begins

As the world reels from the devastating impact and the looming threat of the novel coronavirus COVID-19, researchers around the globe are racing to find a cure that will reduce symptom severity and reverse the course of the disease, freeing up more hospital space and making it possible to treat more of the severely affected cases.

24 Mar 2020

CEL-SCI collaborates with UGA Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy

CEL-SCI Corporation announced today it has signed a collaboration agreement with the University of Georgia’s Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy.

23 Mar 2020

The COVID-19 vaccine pipeline

Major nations are in a race to make an effective vaccine that could help treat the novel coronavirus infection COVID-19. As hundreds of thousands are infected across the world and over sixteen thousand killed, the pandemic shows no signs of relenting.

23 Mar 2020

Researchers show possibility to control cell bioenergetics by changing mitochondria content

Researchers at the University of California, Irvine have shown that they can give cells a short-term boost of energy through mitochondrial transplantation.

23 Mar 2020

Study: One in four of sports students suffers from pain along with psychosocial stresses

They are young and well-trained – but a fourth of sport science students suffers from pain in combination with psychosocial stresses. This was revealed in a study that originated at Goethe University.

23 Mar 2020

Wasan lab develops novel oral formulation to treat systemic fungal infections

The Wasan Laboratory in the Faculty of Pharmaceutical Sciences at the University of British Columbia in partnership with iCo Therapeutics Inc. (Vancouver BC, Canada) have developed a novel oral formulation of Amphotericin B to treat systemic fungal and parasitic infections.

23 Mar 2020

Melinjo seed extract may improve obesity and diabetes

In Southeast Asia, the fruit, flowers, and leaves of Indonesia's "Melinjo" tree are traditional foods.

23 Mar 2020

Changes in 3D genetic structure equally important as DNA code mutations in childhood leukemia

A study found that children with aggressive blood cancers have different superstructures of the proteins that control gene access.

23 Mar 2020

Efficacy News and Research

How effective is social distancing in fighting COVID-19?

Lessons from the Spanish flu: Strict and early isolation really effective in minimizing disease spread

Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19

New research initiative to investigate multi-species response to novel coronavirus

Removing a gene prevents Type 1 diabetes in mice by disguising beta cells

Targeting specific histone deacetylase may be novel therapeutic strategy for NSCLC

Does acupuncture relieve migraines?

Smartphone data helps score US states on social distancing

New molecular probes to study the behavior of opioid receptors

Clinical trial launched to investigate safety and efficacy of antiviral drug for COVID-19

Cannabidiol helps fight antibiotic-resistant bacteria

ELS can be useful in measuring outcomes for treatment studies in intellectual disabilities

Huge WHO trial of COVID-19 therapies begins

CEL-SCI collaborates with UGA Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy

The COVID-19 vaccine pipeline

Researchers show possibility to control cell bioenergetics by changing mitochondria content

Study: One in four of sports students suffers from pain along with psychosocial stresses

Wasan lab develops novel oral formulation to treat systemic fungal infections

Melinjo seed extract may improve obesity and diabetes

Changes in 3D genetic structure equally important as DNA code mutations in childhood leukemia

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News